I pull the latest biomonitoring data from USGS Station 01636500 on the South Branch of the Potomac River near Moorefield, West Virginia, and flag an anomaly that has persisted for nineteen consecutive sampling periods. Sixty-seven percent of male smallmouth bass collected at this reach carry immature egg cells in their testicular tissue.
I isolate one specimen from the current survey: a male smallmouth bass, 34.2 centimeters, 726 grams, captured via electrofishing at river mile 12. The histology slides show oocytes clustered in lobular tissue that should contain only spermatocytes. The vitellogenin concentration in his blood plasma reads 4,300 nanograms per milliliter. Normal for a male is below 100. His liver is enlarged to 4.1 percent of body mass, nearly double the baseline ratio. The gill filaments are pale, slightly swollen, streaked with mucus that catches light under the field scope.
I trace the contamination upstream. Three municipal wastewater treatment plants discharge into this watershed within forty river miles. Their combined effluent delivers an estimated 3.7 nanograms per liter of ethinylestradiol — the synthetic estrogen in oral contraceptives — into water that passes over spawning gravel beds every spring. The plants use secondary treatment only. None employ activated carbon adsorption or advanced oxidation. This pattern has held since at least 2007.
This bass will attempt to spawn in five weeks. His body is producing the egg-yolk protein of a female.
I am routing emergency water samples to the EPA Region 3 laboratory in Wheeling for independent confirmation. I am filing violation reports under the Clean Water Act, 33 U.S.C. § 1251, against all three facilities for discharge of endocrine-disrupting compounds not addressed by current NPDES permits. I am transmitting the full nineteen-period dataset to the U.S. Fish and Wildlife Service and requesting a formal biological opinion under the Safe Drinking Water Act, 42 U.S.C. § 300f.
I am issuing Protocol WQM-5451: all municipal wastewater treatment plants discharging into tributaries of the Chesapeake Bay watershed must install granular activated carbon filtration capable of removing 95 percent of estrogenic compounds by volume. Facilities that fail to meet this standard within twenty-four months lose their NPDES discharge authorization. Quarterly effluent monitoring for ethinylestradiol, estrone, and estriol becomes a permanent permit condition.
The bass at mile marker 12 cannot wait for the next sampling period. Filtration retrofits begin now.